Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa

Fenner, LukasLukasFenner0000-0003-3309-4835Brinkhof, MartinMartinBrinkhofKeiser, OliviaOliviaKeiser0000-0001-8191-2789Weigel, RalfRalfWeigelCornell, MornaMornaCornellMoultrie, HarryHarryMoultrieProzesky, HansHansProzeskyTechnau, KarlKarlTechnauEley, BrianBrianEleyVaz, PaulaPaulaVazPascoe, MargaretMargaretPascoeGiddy, JanetJanetGiddyVan Cutsem, GillesGillesVan CutsemWood, RobinRobinWoodEgger, MatthiasMatthiasEgger0000-0001-7462-5132Davies, Mary-AnnMary-AnnDavies2024-10-102024-10-102010https://boris-portal.unibe.ch/handle/20.500.12422/71767Many HIV-infected children in Southern Africa have been started on antiretroviral therapy (ART), but loss to follow up (LTFU) can be substantial. We analyzed mortality in children retained in care and in all children starting ART, taking LTFU into account.enEarly mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africaarticle10.7892/boris.10242058818500028014900001310.1097/QAI.0b013e3181e0c4cf